Emil William Chynn

US Patent:

8076060, Dec 13, 2011

Filed:

Aug 3, 2004

Appl. No.:

10/910596

Inventors:

Emil William Chynn - New York NY, US

International Classification:

C07Q 1/70
C12Q 1/00
A61K 39/00
A61K 39/21

US Classification:

435 4, 435 5, 424184, 4241881

Abstract:

This invention provides a method whereby a vaccine, particularly a vaccine based on a prophylactic or therapeutic AIDS/HIV vaccine, or other immune-reactive substance is administered to produce an immunologic response that decreases intraocular pressure or has a neuro-protective effect beneficial in the treatment of glaucoma patients. The invention may also be used as a provocative test to diagnose glaucoma as well as identify those patients at risk for developing glaucoma. The invention may also be used to prevent the development of glaucoma in patients deemed to be at high risk of developing glaucoma, such as glaucoma suspects or ocular hypertensive patients.

US Patent:

20080057023, Mar 6, 2008

Filed:

Aug 24, 2007

Appl. No.:

11/844930

Inventors:

Emil W. Chynn - New York NY, US
Chirag Shah - Livingston NJ, US

International Classification:

A61K 31/74
A61P 27/04

US Classification:

424 7804

Abstract:

The present invention relates to oxygenated ophthalmic topical compositions and methods of administering oxygenated ophthalmic topical compositions. The present invention also encompasses methods for making and administering the oxygenated ophthalmic topical compositions for use in treating or ameliorating pathologic conditions, complications, diseases and symptoms related to hypoxia of the anterior eye structure, including corneal neovascularization (CNV), edema, abrasions, infections, infiltrates, dry eye syndrome, contact lens intolerance; and redness, blurred vision, discomfort, foreign body sensation, photophobia, and irritation.

US Patent:

20110177171, Jul 21, 2011

Filed:

Mar 28, 2011

Appl. No.:

13/073995

Inventors:

Emil W. Chynn - New York NY, US

International Classification:

A61K 33/00
A61P 27/02
A61P 31/00
A61P 29/00

US Classification:

424600

Abstract:

The present invention relates to oxygenated ophthalmic topical compositions and methods of administering oxygenated ophthalmic topical compositions. The present invention also encompasses methods for making and administering the oxygenated ophthalmic topical compositions for use in treating or ameliorating pathologic conditions, complications, diseases and symptoms related to hypoxia of the anterior eye structure, including corneal neovascularization (CNV), edema, abrasions, infections, infiltrates, dry eye syndrome, contact lens intolerance; and redness, blurred vision, discomfort, foreign body sensation, photophobia, and irritation.

US Patent:

20120093857, Apr 19, 2012

Filed:

Dec 13, 2011

Appl. No.:

13/324955

Inventors:

Emil William Chynn - New York NY, US

International Classification:

A61K 39/21
A61P 27/02
A61P 27/06
A61K 39/00

US Classification:

4242081, 4241841

Abstract:

This invention provides a method whereby a vaccine, particularly a vaccine based on a prophylactic or therapeutic AIDS/HIV vaccine, or other immune-reactive substance is administered to produce an immunologic response that decreases intraocular pressure or has a neuro-protective effect beneficial in the treatment of glaucoma patients. The invention may also be used as a provocative test to diagnose glaucoma as well as identify those patients at risk for developing glaucoma. The invention may also be used to prevent the development of glaucoma in patients deemed to be at high risk of developing glaucoma, such as glaucoma suspects or ocular hypertensive patients.

US Patent:

62184288, Apr 17, 2001

Filed:

Apr 28, 2000

Appl. No.:

9/561465

Inventors:

Emil Chynn - New York NY

International Classification:

A61K 3135
A61K 324

US Classification:

514459

Abstract:

The current invention is an ophthalmic composition that combines multiple agents necessary to perform a routine eye examination. Preferably, the composition is a mixture of a topical local anesthetic, a pupillary dilating agent, and a dye, all in solution. The composition may also include a preservative, a wetting agent, a diluting agent, and/or a buffer. The preferred composition provides a means to: 1) anesthetize the cornea to allow for pain relief, manipulation and the measurement of intraocular pressure, 2) dye the cornea and conjunctiva to allow for the detection of pathology and for the measurement of intraocular pressure, and 3) dilate the pupil to allow for examination of the optic nerve, macula, retina, retinal vasculature, and peripheral fundus. In addition, the invention includes a method of using the inventive composition and a method of using currently available compositions that allow for a more rapid eye examination by eliminating or reducing a waiting period that follows the administration of dilating agents according to the present state of the art. Moreover, the inventive composition may be used pre-operatively before ophthalmic surgery, thereby conferring many of the same advantages as described above.